Hec Cj Pharm Sustainability Profile
Hec Cj Pharm, officially known as Hec Pharm Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, Hec Cj Pharm is recognised for its commitment to innovation and quality. The company’s unique approach combines advanced technology with rigorous quality control, ensuring that its products meet international standards. With a solid market position, Hec Cj Pharm has achieved notable milestones, including various certifications and partnerships that enhance its reputation in the global market. The company continues to expand its portfolio, contributing significantly to the healthcare sector.
DitchCarbon Score
How does Hec Cj Pharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hec Cj Pharm's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hec Cj Pharm's reported carbon emissions
In 2024, Hec Cj Pharm reported total carbon emissions of approximately 82,394,500 kg CO2e, comprising 520,000 kg CO2e from Scope 1 and 82,874,500 kg CO2e from Scope 2 emissions. This marks a slight increase from 2023, where emissions were about 73,855,000 kg CO2e, with Scope 1 emissions at 510,000 kg CO2e and Scope 2 emissions at 72,855,000 kg CO2e. The company has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. Hec Cj Pharm has not set specific reduction targets or initiatives, as evidenced by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). In the context of its operations in China, the company reported total emissions of approximately 68,798,560 kg CO2e in 2023 and 62,205,490 kg CO2e in 2022. The emissions data reflects a consistent commitment to transparency, although the lack of reduction initiatives suggests an opportunity for Hec Cj Pharm to enhance its climate strategy moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 49,760 | 00,000 | 00,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 34,557,200 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is Hec Cj Pharm's Industry?
How Carbon Intensive is Hec Cj Pharm's Location?
Hec Cj Pharm's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hec Cj Pharm has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
